SCHEMBL127207

SCHEMBL127207

CSc1cc(N(C)C)ccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
ALOX15 P16050 2/20 0.43
CYP3A4 P08684 2/20 0.43
MAPK1 P28482 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
TP53 P04637 1/20 0.43
CRHR1 P34998 1/20 0.42
TSHR P16473 4/20 0.40
HSD17B10 Q99714 1/20 0.40
APAF1 O14727 1/20 0.40
TERT O14746 1/20 0.38
APP P05067 1/20 0.38
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
S100B P04271 1/20 0.33
HDAC1 Q13547 1/20 0.33
NOS3 P29474 2/20 0.33
NOS1 P29475 2/20 0.33
NOS2 P35228 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190887 0.82 ALDH1A1 (0.41) ALDH1A1ALOX15CYP3A4MAPK1TDP1
SCHEMBL14355932 0.81 MAPT (0.49) ALDH1A1ALOX15TDP1APPKDM4E
SCHEMBL10631846 0.80 ALDH1A1 (0.46) ALDH1A1ALOX15CYP3A4MAPK1TDP1
SCHEMBL22753827 0.76 NPC1 (0.44) ALDH1A1ALOX15CYP3A4MAPK1TDP1
SCHEMBL22753824 0.76 NPC1 (0.44) ALDH1A1ALOX15CYP3A4MAPK1TDP1
SCHEMBL5165904 0.75 CASP1 (0.44) ALDH1A1ALOX15CYP3A4TDP1TP53
SCHEMBL2313495 0.75 ALDH1A1 (0.52) ALDH1A1ALOX15CYP3A4MAPK1TDP1
SCHEMBL31361979 0.75 ALDH1A1 (0.52) ALDH1A1ALOX15CYP3A4MAPK1TDP1
SCHEMBL743427 0.74 ALDH1A1 (0.39) ALDH1A1ALOX15CYP3A4MAPK1TDP1
SCHEMBL127303 0.74 ALDH1A1 (0.39) ALDH1A1ALOX15CYP3A4MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8691979-B2 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants WISTA LABORATORIES LTD. (SG) 2014-04-08 US disclosed
US-20120058995-A1 METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INVOLVING THE USE OF PERSULFATE OXIDANTS WISTA LABORATORIES LTD. (SG) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058995-A1 METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INVOLVING THE USE OF PERSULFATE OXIDANTS TST, TPMT, MGMT ALDH1A1 748/4885ALOX15 2129/4885CYP3A4 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.